Moreover, in breast cancer, IGF-1 mainly upregulates cysteine-rich 61 (Cyr61) by activating the PI3K/AKT pathway and an increase in Cyr61 promotes the growth and invasion of breast cancer cells (27)
A 2022 review in Gastroenterology looked at GLP-1 agonist use across multiple trials and found a roughly two-fold increase in acute pancreatitis risk compared to placebo
As of 2024, Medicare Part D plans may cover semaglutide 2.4 mg (Wegovy) when prescribed for its cardiovascular risk reduction indication in eligible patients
Similarly, PET/CT studies, a representative of molecular imaging, have also revolved around 68Ga-exendin-4
People doing well rarely post Day 147 update: still feeling great, no issues. This creates sampling bias where forums and comment sections overrepresent negative experiences while underrepresenting typical experiences
That said, I have unshakeable faith that some enterprising buy-side analyst asked in a small group months or years earlier